Tactile Systems Technology (TCMD)
Tactile IPOd in July of 2016, and since then, shares of TCMD have gone from $11 to $33. This is not some haptic technology company, (you’ll be sick of hearing about that as soon as Ready Player One is released) but rather, a medical device company valued by the market at $592 million. They make devices for the treatment of chronic venous insufficiency and lymphedema. The company is profitable, and revenue is growing at 22% annually. Of course, the real play here, as with all medical device companies, is a bet on the inevitable aging of America, a trend which is sure to continue for at least the next 20 years.
Chart courtesy of www.stockcharts.com